Navigation Links
Study compares cost-effectiveness of weight-loss programs and drugs
Date:7/22/2014

DURHAM, N.C. In a cost-effectiveness analysis of commercial diet programs and pills, the Weight Watchers program and the drug Qsymia showed the best value for the money. The Jenny Craig regimen generated the greatest weight loss, but was also the most expensive option tested, according to researchers at Duke-National University of Singapore (NUS) Graduate Medical School.

The findings, published in the June issue of the journal Obesity, provide important information on the health and weight-loss benefits per dollar spent as insurance carriers consider coverage for weight loss programs and drugs.

"The obesity epidemic is raising serious health and cost consequences, so employers and third-party payers are beginning to consider how to provide some coverage for commercial weight loss programs," said senior author Eric Finkelstein, Ph.D., professor at Duke-NUS and the Duke University Global Health Institute. "These results will help them make better purchasing decisions to maximize the health gains using available resources."

Finkelstein and research assistant Eliza Kruger first conducted a literature review to identify high-quality clinical trials of commercially available diet/lifestyle plans and medications with proven weight loss at one year or more. Weight loss was measured in terms of absolute change in kilograms lost compared to a control group in which patients underwent a low cost/low intensity intervention, or a placebo in the case of the pharmaceutical trials.

Three diet/lifestyle programs and three medications met the inclusion criteria for the cost-effectiveness analysis: Weight Watchers, Jenny Craig and VTrim, along with the diet pills Qsymia, Lorcaserin and Orlistat.

Several meal replacement products were excluded despite showing some weight loss success -- including Medifast, Optifast and Slimfast because they did not meet one or more inclusion criteria. Weight-loss surgery was also excluded.

In terms of cost, Weight Watchers was shown to be the least expensive intervention, consisting of an average annual cost of $377. The expected annual cost for Vtrim users was $682. Because of the relatively high cost of Jenny Craig food, it was the most expensive intervention, with an annual cost of more than $2,500.

Expected annual costs for the diet pills was $1,743 for Lorcaserin; $1,518 for Orlistat; and $1,336 for Qsymia.

Average weight loss at one year ranged from 2.4 kg (about 5 pounds) for Weight Watchers to 7.4 kg (16 pounds) for Jenny Craig. Those on Orlistat lost 2.8 kg (a little more than 6 pounds) whereas those on Vtrim and Lorcaserin both lost an average of 3.2 kg (about 7 pounds). Weight loss for those on Qsymia averaged 6.7kg (a little less than 15 pounds).

Based on the cost and weight-loss data, the average cost per kilogram lost ranged from $155 per kg for Weight Watchers to $338 or more for Jenny Craig. Qsymia came in at $232 per kg.

When the analysis was extended from cost per kilogram lost to cost per quality adjusted life year saved (QALY), the researchers found that Weight Watchers and Qsymia showed the best value for money. QALYs are often used to benchmark the value of a particular health innovation, with high value interventions typically improving QALYs at a rate of $50,000 or better.

"Health policy makers do not understand value in terms of cost per kilogram lost, but if you tell them that an intervention improves QALYs at better than $50K per QALY saved, they recognize that as good value for money," Finkelstein said.

For the remaining interventions, the additional weight loss came at a price higher than what third-party payers would be likely to cover without significant cost-sharing by participants.

"Although containing rising rates of obesity is a public health imperative, employers and third-party payers remain hesitant to sink big money into commercial weight loss strategies," Finkelstein said. "But looking at cost per weight lost or QALY saved, Weight Watchers looked best because it's the least expensive. Qsymia also showed good value for money because the additional weight loss came at a fairly low cost. To remain competitive, the other programs will either need to up the benefits and/or reduce costs, perhaps through cost-sharing or via other incentive strategies."


'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Law that regulates shark fishery is too liberal: UBC study
3. New study will help protect vulnerable birds from impacts of climate change
4. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
5. BYU study: Using a gun in bear encounters doesnt make you safer
6. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
7. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
8. Crystal structure of archael chromatin clarified in new study
9. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
10. University of Houston study shows BP oil spill hurt marshes, but recovery possible
11. Study demonstrates cells can acquire new functions through transcriptional regulatory network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/10/2017)... ... , ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled ... bold new look is part of a transformation to increase awareness, appeal to new ... , It will also expand its service offering from its signature gourmet cooking classes ...
Breaking Biology Technology: